Home › Osteoarthritis › NCT06735027
Corticosteroid Injection Versus Nerve Block
A Randomized Comparative Cohort Study of the Use of Intra-articular Corticosteroid Injection Compared to Suprascapular Nerve Block for Treatment of Shoulder Pain
Who can join
Ages 18 to 99 · All sexes
Full eligibility criteria
Inclusion Criteria: * diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection Exclusion Criteria: * uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater" * known allergy to steroid or anesthetic * pregnant women * prisoners * patients with diminished capacity to consent to participation * children under 18 years of age * non-English speakers
About the study
The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.
What is being tested
- intraarticular corticosteroid injection (IACI) (other)
- suprascapular nerve block (SSNB) (other)
Sponsor: University of Minnesota · Participants: 40 · Started: Jan 2, 2025
Contact the study team
- Allison Rao · Phone: 608-445-0545
Official record on ClinicalTrials.gov — NCT06735027
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.